Editorial Commentary
Immune-checkpoint inhibitors and the importance of concomitant medications: focus on antibiotics
Abstract
Harnessing the immune system to battle cancer, long a medical utopia, is becoming a reality. With the advent of immunotherapy, substantial progresses have been made in improving patients outcome, but only for a minority of them.